Zelluna logo
VerifiedBiotechnology Research· Founded 2016

Zelluna

Zelluna is pioneering allogeneic ‘off-the-shelf’ T Cell Receptor-based Natural Killer (TCR-NK) cells for the treatment of solid cancers. The company’s platform combines the innate killing power of NK cells with precise solid tumour targeting of TCRs, designed to address the limitations of current cell therapies in solid tumours. The company’s lead candidate, ZI-MA4-1, is the worlds-first MAGE-A4 targeting TCR-NK therapy expected to enter clinical trials in 2026 For more info please visit

7-day free trial · no credit card

Employees30(11 to 50)Founded year2016Websitezelluna.comLinkedIn profileLinkedIn

Verified contacts

16

available on Kipplo

LinkedIn employees

30

11 to 50 range

Open roles

no listings

Distinct roles

13

indexed titles

Tech stack

0

tools in use

Monthly traffic

53

organic / mo

Sign up free to see all 16 verified contacts at Zelluna

Free for 7 days · 50 credits · no card · only pay for verified records.

Sign up free

Decision-makers and verified team members

16 contacts with verified email or phone · masked until revealed.

Sign up free →

Top roles at Zelluna

13 distinct titles indexed · top 10 shown.

  • 2()
  • 2scientist
  • 1' - - -',
  • 1chief executive officer
  • 1coo & head of business development
  • 1finance director
  • 1head of clinical operations
  • 1head of office
  • 1lab manager
  • 1principal scientist
  • +3more titles

Sign up to unlock all 16 contacts at Zelluna

Free for 7 days · 50 credits · no card · only pay for verified records.

Sign up free

Sign up to reveal 16 verified contacts at Zelluna

7-day trial · no credit card · cancel anytime · only pay for verified records.

Trusted by sales, marketing, and GTM engineering teams.

Zelluna | Kipplo Discover